x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The Readout Loud

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

business

All Episodes

23:24

Episode 62: Drug pricing partisanship, tech's march...

The Readout Loud ·

2019/05/16

Has drug price reform already stalled? How far has tech come in medicine? And should there be an app for that?

en

25:03

Episode 61: Pharma felonies, cardiac CRISPR, and a...

The Readout Loud ·

2019/05/09

Are law-breaking pharma executives the new mob bosses? Can genome editing preventing heart attacks? And can the FDA regulate drug prices?

en

22:20

Episode 60: Boardroom drama, whiskey-fueled science,...

The Readout Loud ·

2019/05/02

Is Biogen bracing for a fight? What does Jack Daniels have to do with immunotherapy? And will "micro-dosing" light the way to actual therapies?

en

22:17

Episode 59: When scientists get mad online,...

The Readout Loud ·

2019/04/25

Who gets to be "influential"? Should you be skeptical of for-profit hospitals? And should George Lucas fire his attorneys?

en

21:34

Episode 58: Democratizing CRISPR, drugging the...

The Readout Loud ·

2019/04/18

Who gets to "play God"? Can old technologies learn new tricks? And what does "drug price" even mean?

en

25:21

Episode 57: Trump’s drug pricing foot soldier,...

The Readout Loud ·

2019/04/11

How do you sell lefty ideas to righty politicians? What’s going on at Gilead Sciences? And why are biotech investors freaking out?

en

28:51

Episode 56: Cheaper insulin, the next Juul, and...

The Readout Loud ·

2019/04/04

What if pharma just charged less for drugs? Can speaking three syllables reveal whether you're depressed? And why is Snoop Dogg selling erectile dysfunction pills on TV?

en

26:32

Episode 55: The fate of Bristol-Myers-Celgene, the...

The Readout Loud ·

2019/03/28

Why can't investors think for themselves? How do parents cope with inexplicable tragedy? And is tech prepared for the toughest parts of health care?

en

31:04

Episode 54: Another big Alzheimer’s failure,...

The Readout Loud ·

2019/03/21

Should Alzheimer's researchers just give up on amyloid plaques? What will a new drug mean for new moms with postpartum depression? And which coastal region of Long Island is superior?

en

31:45

Episode 53: How startups stop, the new FDA boss, and...

The Readout Loud ·

2019/03/14

Who deserves credit for a new gene therapy? How do you push stop on a startup? And what does MC Hammer have to do with Theranos?

en

28:28

Episode 52: Every conceivable angle of Scott...

The Readout Loud ·

2019/03/07

Why is Scott Gottlieb quitting the FDA? Who will replace him? And what's the proper elastane content of a skinny jean?

en

26:26

Episode 51: CEOs at the Senate, merger mania, and...

The Readout Loud ·

2019/02/28

Is this the age of the big biotech buyout? Is cold brew a business expense? And how do you pronounce "Gonzalez"?

en

13:10

Episode 50: A big scoop on opioid marketing

The Readout Loud ·

2019/02/22

What did an opioid patriarch say under oath? Why did everyone want to know so badly? And how might it shape the conversation around the opioid crisis?

en

23:54

Episode 49: Painkiller racketeering, the limits of...

The Readout Loud ·

2019/02/21

Is pharma about to have its Big Tobacco moment? Are we overestimating human genetics? And can sales reps rap? We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, Boston Globe reporter Jonathan Saltzman joins us to discuss the case against Insys Therapeutics, the maker of a powerful painkiller now accused of running a nationwide racketeering scheme. Then Dr. Laura Esserman of the University of California, San Francisco, comes on to break down the

en

23:46

Episode 48: The AI hype machine, ketamine's future,...

The Readout Loud ·

2019/02/14

When will AI replace your radiologist? What can pharma learn from ketamine? And is liver disease more complicated than anyone thought?

en

26:27

Episode 47: A bad day for bold biotech, campaign...

The Readout Loud ·

2019/02/07

Are we underestimating biology? Will Hot 97 decide the presidency? And who owns the scientific means of production?

en

24:34

Episode 46: Another Alzheimer's setback, crypto for...

The Readout Loud ·

2019/01/31

Is the drug industry wrong about Alzheimer's disease? Can cryptocurrency fund actual science? And should you feel sorry for Big Pharma?

en

24:54

Episode 45: CRISPR upheaval, Celgene's chutzpah, and...

The Readout Loud ·

2019/01/24

Is genome editing harder than anyone thought? Will no one weep for Celgene? And is it time to sequence your dog?

en

23:55

Episode 44: FDA furloughs, '80s pop radio, and video...

The Readout Loud ·

2019/01/17

Is the FDA going broke? Can video games be drugs? And when did "Flashdance" come out?

en

14:45

Episode 43: A people's history of J.P. Morgan

The Readout Loud ·

2019/01/10

Do drug developers tip well? Is biotech safe for 6-year-olds? And what's a Cable Car Cosmo?

en

383 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...